Blog | Inovatie

top of page

Advanced and Innovative Therapies – Regulatory Challenges

Advanced and Innovative Therapies – Regulatory Challenges

Advanced and Innovative Therapies – Regulatory Challenges

May 19

Anvisa announces initiatives to promote access to new medications

Anvisa announces initiatives to promote access to new medications

Anvisa announces initiatives to promote access to new medications

Apr 14

Regulatory Intelligence and the Role of Clinical Studies

Regulatory Intelligence and the Role of Clinical Studies

Regulatory Intelligence and the Role of Clinical Studies

Dec 12, 2024

Anvisa publishes the list of active ingredients of medicines with registration requests under analysis

Anvisa publishes the list of active ingredients of medicines with registration requests under analysis

Anvisa publishes the list of active ingredients of medicines with registration requests under analysis

Oct 17, 2024

We must support Anvisa

We must support Anvisa

We must support Anvisa

Sep 12, 2024

Post-registration of medicines – opportunities and challenges

Post-registration of medicines – opportunities and challenges

Post-registration of medicines – opportunities and challenges

Aug 30, 2024

Clinical Research Law: A Historic Regulatory Milestone for Clinical Trial with Human Beings in Brazil

Clinical Research Law: A Historic Regulatory Milestone for Clinical Trial with Human Beings in Brazil

Clinical Research Law: A Historic Regulatory Milestone for Clinical Trial with Human Beings in Brazil

Aug 12, 2024

GGBIO task force: solution or palliative?

GGBIO task force: solution or palliative?

GGBIO task force: solution or palliative?

Aug 5, 2024

Anvisa: 25 years with many stories to tell

Anvisa: 25 years with many stories to tell

Anvisa: 25 years with many stories to tell

Jul 11, 2024

Challenges in the development and registration of biosimilars

Challenges in the development and registration of biosimilars

Challenges in the development and registration of biosimilars

Jun 27, 2024

Anvisa's General Management of Medicines releases the 2023 Management Report

Anvisa's General Management of Medicines releases the 2023 Management Report

Anvisa's General Management of Medicines releases the 2023 Management Report

Jun 17, 2024

Real-world studies for drug registration: ANVISA guidelines

Real-world studies for drug registration: ANVISA guidelines

Real-world studies for drug registration: ANVISA guidelines

May 31, 2024

Impact of Reliance on the Regulated Sector

Impact of Reliance on the Regulated Sector

Impact of Reliance on the Regulated Sector

May 9, 2024

Clinical Research involving Advanced Therapies: impacts of RDC nº 836, December 2023 - ANVISA / Brazil

Clinical Research involving Advanced Therapies: impacts of RDC nº 836, December 2023 - ANVISA / Brazil

Clinical Research involving Advanced Therapies: impacts of RDC nº 836, December 2023 - ANVISA / Brazil

Apr 18, 2024

Find out about Anvisa's priorities for the next biennium

Find out about Anvisa's priorities for the next biennium

Find out about Anvisa's priorities for the next biennium

Feb 7, 2024

RDC 753 - New Regulatory Framework for the Registration of Synthetic Drugs.

RDC 753 - New Regulatory Framework for the Registration of Synthetic Drugs.

RDC 753 - New Regulatory Framework for the Registration of Synthetic Drugs.

Nov 21, 2023

What are the challenges in ensuring access to high-cost medicines?

What are the challenges in ensuring access to high-cost medicines?

What are the challenges in ensuring access to high-cost medicines?

Nov 6, 2023

WHAT ARE THE STEPS FOR OBTAINING AUTHORIZATION FOR CLINICAL STUDIES IN BRAZIL?

WHAT ARE THE STEPS FOR OBTAINING AUTHORIZATION FOR CLINICAL STUDIES IN BRAZIL?

WHAT ARE THE STEPS FOR OBTAINING AUTHORIZATION FOR CLINICAL STUDIES IN BRAZIL?

Oct 26, 2023

Important circumstances for the submission of drug registration in Brazil

Important circumstances for the submission of drug registration in Brazil

Important circumstances for the submission of drug registration in Brazil

Oct 9, 2023

What are the topics of interest and ANVISA’s availability for meetings?

What are the topics of interest and ANVISA’s availability for meetings?

What are the topics of interest and ANVISA’s availability for meetings?

Sep 29, 2023

2 3 4 5

E-BOOKS

CONTEÚDOS EXCLUSIVOS PARA AUXILIAR EM
SEU TRABALHO

bottom of page